Novavax Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, has updated its leadership team and appointed Gregory F. Covino as executive vice president and chief financial officer (CFO). Executive vice president John Trizzino, who previously served as CFO, will now become the chief commercial officer while continuing in his role as chief business officer.   “We welcome Greg’s multifaceted and extensive global financial experience at a piv...